Price Oliver J, Hull James H, Ansley Les, Thomas Mike, Eyles Caroline
Carnegie School of Sport, Leeds Beckett University, Leeds, UK.
Department of Respiratory Medicine, Royal Brompton Hospital, UK.
Respir Med. 2016 Nov;120:36-43. doi: 10.1016/j.rmed.2016.09.017. Epub 2016 Sep 25.
A poor relationship between perceived respiratory symptoms and objective evidence of exercise-induced bronchoconstriction (EIB) in athletes is often reported; however, the reasons for this disconnect remain unclear. The primary aim of this study was to utilise a qualitative-analytical approach to compare respiratory symptoms in athletes with and without objectively confirmed EIB.
Endurance athletes who had previously undergone bronchoprovocation test screening for EIB were divided into sub-groups, based on the presence or absence of EIB ± heightened self-report of dyspnoea: (i) EIB-Dys- (ii) EIB + Dys+ (iii) EIB + Dys- (iv) EIB-Dys+. All athletes underwent a detailed semi-structured interview.
Twenty athletes completed the study with an equal distribution in each sub-group (n = 5). Thematic analysis of individual narratives resulted in four over-arching themes: 1) Factors aggravating dyspnoea, 2) Exercise limitation, 3) Strategies to control dyspnoea, 4) Diagnostic accuracy. The anatomical location of symptoms varied between EIB + Dys + athletes and EIB-Dys + athletes. All EIB-Dys + reported significantly longer recovery times following high-intensity exercise in comparison to all other sub-groups. Finally, EIB + Dys + reported symptom improvement following beta-2 agonist therapy, whereas EIB-Dys + deemed treatment ineffective.
A detailed qualitative approach to the assessment of breathlessness reveals few features that distinguish between EIB and non-EIB causes of exertional dyspnoea in athletes. Important differences that may provide value in clinical work-up include (i) location of symptoms, (ii) recovery time following exercise and (iii) response to beta-2 agonist therapy. Overall these findings may inform clinical evaluation and development of future questionnaires to aid clinic-based assessment of athletes with dyspnoea.
经常有报道称,运动员所感知到的呼吸道症状与运动诱发支气管收缩(EIB)的客观证据之间关系不佳;然而,这种脱节的原因仍不清楚。本研究的主要目的是采用定性分析方法,比较有和没有经客观证实的EIB的运动员的呼吸道症状。
曾接受过EIB支气管激发试验筛查的耐力运动员,根据是否存在EIB以及是否有呼吸困难自我报告增加,被分为亚组:(i)EIB-呼吸困难-(ii)EIB+呼吸困难+(iii)EIB+呼吸困难-(iv)EIB-呼吸困难+。所有运动员都接受了详细的半结构化访谈。
20名运动员完成了研究,每个亚组人数均等(n = 5)。对个人叙述的主题分析产生了四个总体主题:1)加重呼吸困难的因素,2)运动限制,3)控制呼吸困难的策略,4)诊断准确性。EIB+呼吸困难+运动员和EIB-呼吸困难+运动员的症状解剖位置有所不同。与所有其他亚组相比,所有EIB-呼吸困难+的运动员报告称,高强度运动后的恢复时间明显更长。最后,EIB+呼吸困难+的运动员报告称,β-2激动剂治疗后症状有所改善,而EIB-呼吸困难+的运动员认为治疗无效。
对呼吸急促进行详细的定性评估方法显示,在区分运动员运动性呼吸困难的EIB和非EIB原因方面,几乎没有什么特征。可能在临床检查中具有价值的重要差异包括:(i)症状位置,(ii)运动后的恢复时间,以及(iii)对β-2激动剂治疗的反应。总体而言,这些发现可能为临床评估和未来问卷的开发提供参考,以帮助对有呼吸困难的运动员进行基于诊所的评估。